Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04931589
Other study ID # 2020-004
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date June 11, 2021

Study information

Verified date January 2021
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, the "Curve of Intraoperative Body Temperature Change in Patients with VATS Surgery" was taken as the main research content to retrospectively analyze the intraoperative body temperature and its change rules of patients who met the research conditions, and draw a trend curve, namely, the curve of body temperature change.Taking "time" as the independent variable and "body temperature" as the dependent variable, the correlation between the two was statistically analyzed.Through the development of the body temperature change curve, we can further understand the phenomenon that the body temperature of patients undergoing VATS surgery changes with the progress of surgery, and longitudinal understand the change trend and the general rule of the body temperature change.The results can provide a basis for clinical development of scientific preoperative evaluation plan, hypothermia prevention strategy and intraoperative intervention plan.


Description:

Lung cancer is a common malignant tumor. With the increasingly serious air pollution and the arrival of the aging society, the prevalence of lung cancer is increasing year by year.According to the Globocan 2018 Cancer Report, published 2018 by the International Agency for Research on Cancer (IARC) of the World Health Organization,Lung cancer accounted for 11.6% of new cases and 18.4% of deaths from malignancies globally in 2018, ranking first among malignancies.As the mainstream surgical treatment of lung cancer, video-assisted thoracic surgery (VATS) has many advantages such as less trauma and rapid recovery of patients, and has become one of the preferred methods for the treatment of lung cancer, especially early lung cancer.It has been widely used at home and abroad.However, with the more and more extensive development of VATS surgery, the phenomenon of intraoperative hypothermia in patients is relatively common clinically.The study results of Cywinski et al. showed that the rate of hypothermia after thoracoscopic surgery could reach 50%.Intraoperative hypothermia can lead to adverse effects such as increased cardiovascular events, coagulation dysfunction, prolonged wound recovery time, increased risk of wound infection, immune system suppression, and slow drug metabolism [7]. Perioperative hypothermia means that the body's core body temperature is less than 36℃ due to various reasons during the perioperative period, also known as perioperative unexpected hypothermia or unplanned perioperative hypothermia.Perioperative hypothermia can be caused by any factor that may affect thermoregulation.Risk factors affecting thermoregulation mainly include patient anesthesia factors, self factors, surgical factors, environmental factors, etc. [13].Operation when the room temperature is too low, inadequate coverage and other factors leading to excessive heat loss surgery (room temperature as a given intravenous fluids and rinses, evaporation of the skin disinfectant, etc.), lead to the low temperature of unplanned, patients not only affect the function of blood coagulation, lead to increased perioperative blood loss, also can increase the risk of cardiovascular events, and can suppress the immune function,It can lead to postoperative infection and even more serious adverse outcomes.Intraoperative hypothermia involved in this study includes perioperative hypothermia, which is an important clinical manifestation of perioperative hypothermia.It is found in clinical practice that the proportion of intraoperative hypothermia in patients undergoing VATS surgery is high, which is closely related to the specific surgical position and surgical site. Current studies on intraoperative hypothermia in patients undergoing VATS surgery [15-16] mainly focus on the comparison of intervention methods, including the selection of intervention methods, the effect comparison of heating equipment, or the effect comparison of heating sites.However, there has been no in-depth study on the specific changes of body temperature and the trend of body temperature changes during VATS surgery.At the same time, the intervention time point for intraoperative hypothermia is mainly judged by clinical experience, and there is a lack of support from objective data studies.Clinical observation shows that the changes of body temperature in patients undergoing VATS surgery are not a straight line, nor a simple arc, but a curve that changes continuously with the operation time. In this study, the "Curve of Intraoperative Body Temperature Change in Patients with VATS Surgery" was taken as the main research content to retrospectively analyze the intraoperative body temperature and its change rules of patients who met the research conditions, and draw a trend curve, namely, the curve of body temperature change.Taking "time" as the independent variable and "body temperature" as the dependent variable, the correlation between the two was statistically analyzed.Through the development of the body temperature change curve, we can further understand the phenomenon that the body temperature of patients undergoing VATS surgery changes with the progress of surgery, and longitudinal understand the change trend and the general rule of the body temperature change.The results can provide a basis for clinical development of scientific preoperative evaluation plan, hypothermia prevention strategy and intraoperative intervention plan.Moreover, it can further study the influence of various factors, such as surgical factors, anesthesia factors and patients' own factors, on the temperature change curve, so as to provide a basis for clinical intervention.


Recruitment information / eligibility

Status Completed
Enrollment 2156
Est. completion date June 11, 2021
Est. primary completion date May 30, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - ? Endoscopic radical resection of lung cancer was performed with a single or porous approach.? Continuous monitoring of nasopharyngeal temperature was recorded during the whole operation (the system automatically recorded once every 5min);? The preoperative basal metabolism was normal, and the basal body temperature was 36.5?<T0<37.5? (the preoperative average body temperature in hospital);(4) total subvenous tracheal intubation anesthesia; Exclusion Criteria: - Patients with the minimum intraoperative temperature monitoring data >36.0?;Cases with warm intervention immediately after the start of surgery;Patients undergoing combined surgery for other types or organs;Intraoperative monitoring of body temperature was discontinuous or abnormal (monitoring catheter was accidentally pulled out, etc.);Intraoperative endoscopic change cases;Other cases that do not meet the requirements of the study, such as individual data anomalies or cases that are far more specific than the general cases (the cases themselves are special or caused by human recording errors).

Study Design


Locations

Country Name City State
China 2nd Affiliated Hospital Hangzhou Zhejiang

Sponsors (4)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University First Affiliated Hospital of Wenzhou Medical University, Zhejiang Cancer Hospital, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body temperature Temperature per 5 minutes during the operation Estimated time for each operation is 60-240 minutes
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk